In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2

por Kim, S, Mohapatra, G, Haber, D A
Publicado 2008

Mammographic density, lobular involution, and risk of breast cancer

por Ginsburg, O M, Martin, L J, Boyd, N F
Publicado 2008

The PRMT1 gene expression pattern in colon cancer

por Mathioudaki, K, Papadokostopoulou, A, Scorilas, A, Xynopoulos, D, Agnanti, N, Talieri, M
Publicado 2008

Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan

por Kurahashi, N, Inoue, M, Iwasaki, M, Tanaka, Y, Mizokami, M, Tsugane, S
Publicado 2009

Reversibility of apoptosis in cancer cells

por Tang, H L, Yuen, K L, Tang, H M, Fung, M C
Publicado 2009

The total hospital and community UK costs of managing patients with relapsed breast cancer

por Thomas, R J, Williams, M, Marshall, C, Glen, J, Callam, M
Publicado 2009

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)

por Plowright, L, Harrington, K J, Pandha, H S, Morgan, R
Publicado 2009

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

por Ueno, H, Kaniwa, N, Okusaka, T, Ikeda, M, Morizane, C, Kondo, S, Sugiyama, E, Kim, S R, Hasegawa, R, Saito, Y, Yoshida, T, Saijo, N, Sawada, J
Publicado 2009

Targeting HSP90 for cancer therapy

por Mahalingam, D, Swords, R, Carew, J S, Nawrocki, S T, Bhalla, K, Giles, F J
Publicado 2009

Bevacizumab combined with gemcitabine and capecitabine for advanced pancreatic cancer: a phase II study

por Javle, M, Yu, J, Garrett, C, Pande, A, Kuvshinoff, B, Litwin, A, Phelan, J, Gibbs, J, Iyer, R
Publicado 2009

A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas

por Schreiber, T H, Podack, E R
Publicado 2009

Human papilloma virus is associated with breast cancer

por Heng, B, Glenn, W K, Ye, Y, Tran, B, Delprado, W, Lutze-Mann, L, Whitaker, N J, Lawson, J S
Publicado 2009

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas

por Edmunds, S C, Cree, I A, Dí Nícolantonío, F, Hungerford, J L, Hurren, J S, Kelsell, D P
Publicado 2003

Possible associations between ELF electromagnetic fields, DNA damage response processes and childhood leukaemia

por Hone, P, Edwards, A, Halls, J, Cox, R, Lloyd, D
Publicado 2003

Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?

por Handgretinger, R, Leung, W, Ihm, K, Lang, P, Klingebiel, T, Niethammer, D
Publicado 2003

Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas

por Zahlten-Hinguranage, A, Bernd, L, Ewerbeck, V, Sabo, D
Publicado 2004

Primary ovarian cancer chemotherapy: current standards of care

por McGuire, W P, Markman, M
Publicado 2003

Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies

por Vasey, P A
Publicado 2003

Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action

por Osborne, C K, Wakeling, A, Nicholson, R I
Publicado 2004

Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets

por Eilbert, K W, Carroll, K, Peach, J, Khatoon, S, Basnett, I, McCulloch, N
Publicado 2009